aneuploidy

Myriad Genetics Bets Fetal DNA Enrichment Method Will Further Increase Uptake of NIPS Test

Natera Expects Further Growth in NIPT as it Expands Use Cases for Cancer, Transplant Tests

Humana Broadens Coverage of NIPT for Average Risk Pregnancies

Yourgene H1 Revenues Up 5 Percent

Yourgene Inks US Distribution Deal for Chemotoxicity Assay, Other Tests

SVB Leerink Initiates Coverage of Natera With Outperform Rating

ACOG Guidelines Recommend NIPT for All Pregnancies Regardless of Risk

Natera Revenues Climb 16 Percent in Q2 Driven by Reproductive Health Business

Yourgene Health Records £2.3M Net Loss for Fiscal Year 2020

Thermo Fisher Scientific, First Genetics to Develop NGS-Based Diagnostics in Russia

Progenity Asks Court to Declare Non-Infringement of Natera Patents

Natera and Illumina Settle Patent Suit, Sign License Agreement, Amend Supply Deal

Natera Q1 Revenues Grow 41 Percent

Yourgene Health Fiscal 2020 Revenues Up 86 Percent

Natera Expects 35 Percent Rise in Q1 Revenues, Proposes $250M Senior Notes Offering

Yourgene Health Acquiring French Distributor of NIPT Test for up to €4.1M

Yourgene Health Revenues Nearly Double in H1 of FY2019